Related Experiment Video
Updated: May 22, 2026

Protocols for Analyzing the Role of Paneth Cells in Regenerating the Murine Intestine using Conditional Cre-lox Mouse Models
Published on: November 21, 2015
SIGIRR, a negative regulator of colon tumorigenesis
Junjie Zhao1, Jarod Zepp, Katarzyna Bulek
1Department of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
Abstract:
Inappropriate activation of the Toll-IL-1R (TL-IL-1) signaling by commensal bacteria contributes to the pathogenesis of inflammatory bowel diseases and colitis-associated cancer. Recent studies have identified SIGIRR as a negative regulator of TL-IL-1 signaling. It dampens intestinal inflammation and tumorigenesis in the colon. In this review, we will discuss the role of SIGIRR in different cell types and the mechanisms underlying its tumor suppressor function.
Insights
SIGIRR negatively regulates Toll-IL-1R signaling, dampening inflammation and tumor growth in the gut. This review explores SIGIRR
Area of Science:
- Immunology
- Gastroenterology
- Oncology
Background:
- Toll-IL-1R (TL-IL-1) signaling, activated by gut bacteria, drives inflammatory bowel diseases and colitis-associated cancer.
- SIGIRR acts as a crucial negative regulator of TL-IL-1 signaling pathways.
- SIGIRR's role in suppressing intestinal inflammation and tumorigenesis is increasingly recognized.
Purpose of the Study:
- To review the multifaceted role of SIGIRR in various intestinal cell types.
- To elucidate the molecular mechanisms by which SIGIRR exerts its tumor suppressor functions.
- To highlight SIGIRR's therapeutic potential in managing gastrointestinal inflammatory and neoplastic diseases.
Main Methods:
- Comprehensive literature review of studies investigating SIGIRR.
- Analysis of preclinical models and human studies on TL-IL-1R signaling and SIGIRR.
- Examination of cellular and molecular pathways regulated by SIGIRR.
Main Results:
- SIGIRR effectively inhibits TL-IL-1R-mediated inflammatory responses in the colon.
- SIGIRR demonstrates significant tumor suppressor activity against colitis-associated cancer.
- SIGIRR's function is cell-type specific, influencing immune and epithelial cells differently.
Conclusions:
- SIGIRR is a key modulator of intestinal homeostasis and a potent suppressor of inflammation and cancer.
- Understanding SIGIRR's mechanisms offers novel therapeutic strategies for inflammatory bowel diseases and colorectal cancer.
- Further research into SIGIRR signaling is warranted to fully exploit its clinical potential.
Related Concept Videos
Negative Regulator Molecules
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Experimental RNAi
